MAIA Biotechnology, Inc., ("MAIA", the "Company"), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced that it has entered into definitive ...

Researchers have developed a machine learning model called DreaMS, which significantly accelerates the analysis of previously unknown molecules. The study is published in Nature Biotechnology.

Lawmakers in Iowa, Idaho, Texas, and Kentucky have introduced bills that would ban or restrict vaccines that use messenger ...

Discover the key biotech trends moving the industry forward in Europe at a time when there lies uncertainty in global ...